Pharmacokinetic and tolerability of mycophenolate mofetil in horses
Drug monitoring should include frequent hemograms and serum biochemical profiles
Additional efficacious immunomodulatory treatment is needed for the management of immune-mediated disease in horses. Mycophenolate mofetil (MMF) is an immunosuppressive drug that warrants assessment as a viable therapeutic agent for horses. The objective of this study was to evaluate the pharmacokinetics (PK) of multiple-day oral dosing of MMF in healthy horses and to determine the tolerability of this dosing regimen.
Six healthy Standardbred mares received MMF 10 mg/kg PO q12h for 7 days in the fed state. Serial sampling was performed over 12 hours on Days 1 and 7 with trough samples collected every 24 hours, immediately before morning drug administration. ...
To read the full article you must log in with your EGO codes.